Literature DB >> 29989343

Regulation of translation initiation factor eIF2B at the hub of the integrated stress response.

Graham D Pavitt1.   

Abstract

Phosphorylation of the translation initiation factor eIF2 is one of the most widely used and well-studied mechanisms cells use to respond to diverse cellular stresses. Known as the integrated stress response (ISR), the control pathway uses modulation of protein synthesis to reprogram gene expression and restore homeostasis. Here the current knowledge of the molecular mechanisms of eIF2 activation and its control by phosphorylation at a single-conserved phosphorylation site, serine 51 are discussed with a major focus on the regulatory roles of eIF2B and eIF5 where a current molecular view of ISR control of eIF2B activity is presented. How genetic disorders affect eIF2 or eIF2B is discussed, as are syndromes where excess signaling through the ISR is a component. Finally, studies into the action of recently identified compounds that modulate the ISR in experimental systems are discussed; these suggest that eIF2B is a potential therapeutic target for a wide range of conditions. This article is categorized under: Translation > Translation Regulation.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  ISRIB; eIF2 phosphorylation; integrated stress response; translational control; vanishing white matter disease

Mesh:

Substances:

Year:  2018        PMID: 29989343     DOI: 10.1002/wrna.1491

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  32 in total

1.  eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes.

Authors:  Melisa Herrero; Shir Mandelboum; Orna Elroy-Stein
Journal:  Neuromolecular Med       Date:  2019-05-27       Impact factor: 3.843

Review 2.  uORF-mediated translational control: recently elucidated mechanisms and implications in cancer.

Authors:  Hung-Hsi Chen; Woan-Yuh Tarn
Journal:  RNA Biol       Date:  2019-06-24       Impact factor: 4.652

3.  Reprogramming of translation in yeast cells impaired for ribosome recycling favors short, efficiently translated mRNAs.

Authors:  Swati Gaikwad; Fardin Ghobakhlou; David J Young; Jyothsna Visweswaraiah; Hongen Zhang; Alan G Hinnebusch
Journal:  Elife       Date:  2021-03-25       Impact factor: 8.140

4.  Missing in Action: Dysfunctional RNA Metabolism in Oligodendroglial Cells as a Contributor to Neurodegenerative Diseases?

Authors:  Peter Hoch-Kraft; Jacqueline Trotter; Constantin Gonsior
Journal:  Neurochem Res       Date:  2019-03-06       Impact factor: 3.996

Review 5.  RNA-binding proteins in human genetic disease.

Authors:  Fátima Gebauer; Thomas Schwarzl; Juan Valcárcel; Matthias W Hentze
Journal:  Nat Rev Genet       Date:  2020-11-24       Impact factor: 53.242

6.  The gene for the lysosomal protein LAMP3 is a direct target of the transcription factor ATF4.

Authors:  Thomas D Burton; Anthony O Fedele; Jianling Xie; Lauren Y Sandeman; Christopher G Proud
Journal:  J Biol Chem       Date:  2020-04-20       Impact factor: 5.157

7.  Small Molecule Modulation of the Integrated Stress Response Governs the Keratoconic Phenotype In Vitro.

Authors:  Uri Simcha Soiberman; Ahmed Elsayed Mahmoud Shehata; Michelle Xiaoyi Lu; Tempest Young; Yassine J Daoud; Shukti Chakravarti; Albert S Jun; James William Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-08-01       Impact factor: 4.799

Review 8.  Roles of polyamines in translation.

Authors:  Thomas E Dever; Ivaylo P Ivanov
Journal:  J Biol Chem       Date:  2018-10-15       Impact factor: 5.157

9.  Quantifying the Binding of Fluorescently Labeled Guanine Nucleotides and Initiator tRNA to Eukaryotic Translation Initiation Factor 2.

Authors:  Martin D Jennings; Graham D Pavitt
Journal:  Methods Mol Biol       Date:  2022

10.  Cyclosporin A but not FK506 activates the integrated stress response in human cells.

Authors:  Anthony O Fedele; Valérie Carraro; Jianling Xie; Julien Averous; Christopher G Proud
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.